Table 2.
Normal (n = 933, 84%) | Atypical squamous cells (n = 66, 6%) | Low-grade squamous intraepithelial lesion (n = 60, 6%) | High-grade squamous intraepithelial lesion (n = 35, 3%) | Atypical glandular cells of undetermined significance (n = 11, 1%) | |
---|---|---|---|---|---|
Year | |||||
1999 (24%) | 86 | 7 | 5 | 1 | 1 |
2000 (26%) | 82 | 8 | 5 | 3 | 2 |
2001 (26%) | 84 | 6 | 4 | 5 | 1 |
2002 (24%) | 85 | 3 | 8 | 3 | 1 |
Age | |||||
16–40 (43%) | 79 | 8 | 7 | 5 | 1 |
41–60 (41%) | 86 | 5 | 6 | 2 | 1 |
61–80 (15%) | 93 | 4 | 1 | 1 | 1 |
80–87 (1%) | 100 | 0 | 0 | 0 | 0 |
Ethnicity | |||||
White (35%) | 89 | 5 | 4 | 1 | 1 |
Black (62%) | 82 | 7 | 6 | 4 | 1 |
Other (3%) | 92 | 3 | 5 | 0 | 0 |
Service | |||||
Neurological (9%) | 91 | 6 | 2 | 0 | 1 |
Psychological (25%) | 87 | 7 | 3 | 2 | 1 |
AIDS (5%) | 52 | 7 | 32 | 9 | 0 |
Medicine (48%) | 84 | 6 | 5 | 4 | 1 |
Surgery (11%) | 90 | 5 | 2 | 1 | 2 |
Other (2%) | 87 | 4 | 0 | 4 | 4 |
HIV status | |||||
Positive (14%) | 54 | 11 | 24 | 11 | 1 |
Negative/Unknown (86%) | 90 | 5 | 2 | 2 | 1 |
Insurance status | |||||
Insured (74%) | 85 | 6 | 5 | 3 | 1 |
Self-pay (26%) | 83 | 5 | 7 | 5 | 0 |
History of sexually transmitted disease | |||||
Yes (28%) | 76 | 8 | 10 | 5 | 1 |
No/Unsure (72%) | 87 | 5 | 4 | 3 | 1 |
History of abnormal Pap test results | |||||
Yes (14%) | 67 | 9 | 16 | 7 | 1 |
No/Unsure (86%) | 87 | 5 | 4 | 3 | 1 |
Years since last Pap test | |||||
< 3 (57%) | 85 | 6 | 5 | 3 | 1 |
3–5 (9%) | 85 | 3 | 9 | 3 | 0 |
> 5 (15%) | 89 | 4 | 5 | 1 | 1 |
Never (1%) | 91 | 0 | 9 | 0 | 0 |
Unsure (18%) | 79 | 8 | 6 | 5 | 2 |
Data are presented as percentages.
Analysis includes 1,105 of 1,117 women given Pap tests between January 1, 1999, and December 12, 2002. Twelve women were not included due to adenocarcinoma (1), endometrial cells/lesions (9), and unsatisfactory specimen taken (2).